Urinary tract infection and Secretion discharge

Summary:

Secretion discharge is found among people with Urinary tract infection, especially for people who are female, 60+ old.

The study analyzes which people have Secretion discharge with Urinary tract infection. It is created by eHealthMe based on reports of 38 people who have Urinary tract infection from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.

What is Urinary tract infection?

Urinary tract infection is found to be associated with 3,014 drugs and 3,958 conditions by eHealthMe. Check the latest studies of Urinary tract infection.

What is Secretion discharge?

Secretion discharge is found to be associated with 829 drugs and 784 conditions by eHealthMe. Check the latest studies of Secretion discharge.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.



On Sep, 02, 2026

38 people who have Urinary Tract Infection and Secretion Discharge are studied.

Would you have Secretion discharge when you have Urinary tract infection?

Gender of people who have Urinary Tract Infection and experienced Secretion Discharge *:

  • female: 75 %
  • male: 25 %

Age of people who have Urinary Tract Infection and experienced Secretion Discharge *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 3.23 %
  • 40-49: 0.0 %
  • 50-59: 3.23 %
  • 60+: 93.55 %

Common co-existing conditions for these people *:

  1. Chronic Myeloid Leukaemia (long lasting type of cancer that starts in the blood-forming cells of the bone marrow and invades the blood): 6 people, 15.79%
  2. Prostate Cancer: 3 people, 7.89%
  3. Sinus Disorder (disease of sinus): 3 people, 7.89%
  4. Ovarian Cancer (cancer of ovary): 2 people, 5.26%
  5. Metastasis (spreadable cancer to other organ from origin): 2 people, 5.26%
  6. Heart Rate Irregular: 1 person, 2.63%
  7. Chronic Obstructive Pulmonary Disease (a progressive disease that makes it hard to breathe): 1 person, 2.63%
  8. Delusion (a false belief or opinion): 1 person, 2.63%
  9. Dermatitis (inflammation of the skin resulting from direct irritation by an external agent or an allergic reaction to it): 1 person, 2.63%
  10. Gastrointestinal Stromal Tumor: 1 person, 2.63%

Common drugs taken by these people *:

  1. Metformin: 17 people, 44.74%
  2. Januvia: 15 people, 39.47%
  3. Ventolin: 8 people, 21.05%
  4. Tasigna: 8 people, 21.05%
  5. Crestor: 8 people, 21.05%
  6. Macrobid: 7 people, 18.42%
  7. Nilotinib Hydrochloride: 7 people, 18.42%
  8. Cipro: 6 people, 15.79%
  9. Sprycel: 6 people, 15.79%
  10. Gliclazide: 4 people, 10.53%

Common symptoms for these people *:

  1. Rashes (redness): 19 people, 50.00%
  2. Cough: 19 people, 50.00%
  3. Peripheral Swelling: 19 people, 50.00%
  4. Itching: 18 people, 47.37%
  5. Nasopharyngitis (inflammation of the nasopharynx): 18 people, 47.37%
  6. Malaise (a feeling of general discomfort or uneasiness): 17 people, 44.74%
  7. Constipation: 17 people, 44.74%
  8. Dyspnea (difficult or laboured breathing): 17 people, 44.74%
  9. Back Pain: 16 people, 42.11%
  10. Drug Hypersensitivity: 15 people, 39.47%

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Secretion discharge?

- Check whether Secretion discharge is associated with a drug or a condition


Related studies:

Treatments, associated drugs and conditions:

All the drugs that are associated with Secretion discharge:

All the conditions that are associated with Secretion discharge:


How the study uses the data?

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

The study is based on Secretion discharge and Urinary tract infection, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: